Organization (Industry)
Investor Aktiebolag
ClinicalTrials.gov lists Investor Aktiebolag as lead sponsor of 58 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
22 sections measured, none recorded
Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Investor Aktiebolag and 5 companies grouped under it: 58 lead-sponsored trials (0 its own, 58 in the grouped companies) and 9 legal-entity registrations (2 its own, 7 in the grouped companies).
Companies grouped under this page (5)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Mölnlycke Health Care AB | 58 | 2 |
| Atlas Antibodies AB | 0 | 2 |
| Mölnlycke Health Care (United Kingdom) | 0 | 1 |
| Permobil Holding AB | 0 | 1 |
| Vectura AB | 0 | 1 |
Manufacturing and distribution sites (6)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| MOLNLYCKE HEALTH CARE | OLDHAM Oldham, GB | FDA | Mölnlycke Health Care (United Kingdom) |
| PERMOBIL, INC. | LEBANON, US | FDA | Permobil (United States) |
| Molnlycke Health Care Oy | Mikkeli Etela-Savo, FI | FDA | Molnlycke Health Care Oy |
| VECTURA LIMITED | CHIPPENHAM, GB | EMA | Vectura (United Kingdom) |
| MOLNLYCKE HEALTH CARE (THAILAND), LTD. | Amphur Muang Chonburi Chon Buri, TH | FDA | Molnlycke Health Care (Thailand), Ltd. |
Showing 5 of 6 sites.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, disease areas, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, journals published in, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, organization relationships, latest dated events, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.